Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination
Objective: To evaluate utility of the DRS-II Total Score for stratifying cognitive status in PD patients without frank cognitive impairment. Background: The DRS-II, a screening…Affective theory of mind in Parkinson’s disease
Objective: The aim of this study is to assess the hypothesis that patients with PD may show difficulties in tasks related to affective theory of…Magnetic resonance characteristic of Parkinson’s disease based on the presence of cognitive impairment
Objective: To study the performance of MRI in patients with Parkinson's disease, depending on the stage of the disease. Background: Steadily progressive chronic neurodegenerative disease…Frequency and characteristics of diplopia in non-demented patients with Parkinson’s disease
Objective: To assess the frequency of diplopia and its relation to motor and non-motor symptoms in a cross sectional sample of non-demented patients with idiopathic…Chronic cerebral hypoperfusion accelerates cognitive dysfunction and microvascular impairment in the MPTP mouse model of Parkinson’s disease
Objective: To evaluate cerebral hypoperfusion on cognitive dysfunction and related microvascular impairment in the MPTP mouse model. Background: Vascular pathology and Parkinson's disease (PD) pathology…Disruption of functional connectivity in Parkinson’s disease patients presenting phonemic fluency impairment
Objective: This study was designed to clarify the changes of detailed functional connectivity in association with phonemic fluency deficits in Parkinson's disease (PD) patients using…Cognitive development in individuals with mild Parkinsonian signs
Objective: With this study we aimed to prospectively evaluate the development of cognitive performance in individuals with persistent Mild Parkinsonian Signs (MPS) compared to neurologically…Comparison of the utility of three cognitive scales for MDS Level-I diagnosis of mild cognitive impairment in Parkinson’s disease: MoCA, PD-CRS and ACE-III
Objective: To compare the utility for detecting Mild Cognitive Impairment in Parkinson's disease (PD-MCI) of three abbreviated global scales: the Montreal Cognitive Assessment (MoCA), the…Cytokines in CSF and plasma as potential biomarkers for PD cognitive impairment
Objective: To assess CSF and plasmatic levels of cytokines as potential biomarkers of PD and PD mild cognitive impairment (PD-MCI). Background: Neuroinflammation may play a…Participation in cognitively-stimulating activities and computer use are associated with better cognitive performance in Parkinson’s disease independent from nigrostriatal dopaminergic and cortical cholinergic degenerations
Objective: To investigate the relationship between times spent with cognitively stimulating activities and cognitive functions in Parkinson's disease (PD) while accounting for the degree of…
- « Previous Page
- 1
- …
- 109
- 110
- 111
- 112
- 113
- …
- 117
- Next Page »